With COVID-19 Positivity Rate Soaring, Long Island Getting Proactive To Beat Back The Surge

Mount Sinai Researchers Develop Method to Identify Dormant Cells That Carry HIV

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

Mount Sinai Receives $6.2 Million Grant from the Steven & Alexandra Cohen Foundation for the Clinical Care of Long Lyme Disease

Icahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic Test Epigenetic /AI Platform to GNOMX Corp.

Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV

Mount Sinai Receives NIH Grant to Develop Vaccines That Can Protect Against Many Different Types of Coronaviruses

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission

A Valuable COVID Drug Doesn’t Work against New Variants

Mount Sinai study finds inflammatory markers that may predict response in some patients to Covid immunotherapies

Scientists identify biomarkers that could help diagnose Lyme disease

Mount Sinai Geriatricians to Develop Model Health Care Program for Older Adults With HIV